GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract HHSN272201400040CALTIMMUNE, INC.

Overview

Award facts

Net obligations
$14.72M
$14,720,895of $14.72M potential value
Outlays (paid to date)
$0
$0 paid of $14.72M obligated$0
Period of performance
Jul 23, 2014 to Sep 7, 2019
Ended
Modifications
12
Latest action Jun 13, 2022
Contract type
Definitive contract
PIID HHSN272201400040C

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

IGF::OT::IGF DEVELOPMENT OF VACCINE FORMULATIONS EFFECTIVE AGAINST NIAID PRIORITY PATHOGENS

Dates and value

Award date
Signed on Jul 23, 2014
Potential end of performance
Sep 6, 2019
Current value
$14,720,895Base and exercised options
Potential value (if all options are exercised)
$14,720,895

Obligations by fiscal year of action

  • FY2022: -$331,984 (de-obligation)
  • FY2021: -$199,149 (de-obligation)
  • FY2019: -$51,839 (de-obligation)
  • FY2017: $4,028,420
  • FY2016: $3,818,071
  • FY2015: $2,250,652
  • FY2014: $5,206,725

Total across 7 fiscal years: $14,720,895

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 13, 2022. View on USAspending · Recipient on SAM.gov

Recipient

LocationGAITHERSBURG, MD
UEIHCX2XDMYTA35
CAGE code1ZG60
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyALTIMMUNE, INC.

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Annapolis, Anne Arundel County, Maryland 21401-3481
Congressional district (place of performance)
MD-03As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Basic researchBR
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
7

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
Yes
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not a bundled requirementD
Consolidated requirement
No
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jul 23, 2014Base obligation at award: $5,206,725
Latest action
Jun 13, 2022 — Other administrative actionModification P00012; administrative: no change in scope or value
Latest substantive action
Apr 17, 2018 — Supplemental agreement (within scope)Modification 7
Latest funding action
Sep 2, 2021 — Funding onlyModification P00010; obligation change -$199,149; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Option exercised5
  • Funding only2
  • Other administrative action2
  • Supplemental agreement (within scope)1
  • Closeout1
  • Vendor identifier change (novation)1
13 actions recorded, Jul 23, 2014 to Jun 13, 2022; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Closely associatedCL
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
13

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2014/2014-0885-000
  • 075-2016/2016-0885-000
  • 075-2017/2017-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression